India Drafts Law To Put Onus On Drug Firms For Trial Errors
This article was originally published in PharmAsia News
India's health ministry plans a law that includes a provision that would require drug makers to prove their clinical trials did not cause a death or injury to a participant bringing suit
You may also be interested in...
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.
The German biotech has developed its COVID-19 vaccine in record-breaking time, but artificial intelligence could help accelerate drug discovery over the longer term.
Denmark’s biotech Genmab has dropped the AXL targeted antibody-drug conjugate, enapotamab vedotin from early clinical development, and is focusing its resources on other therapeutic programs.